Assam Tea and Health
The Authority's standing record on Assam tea and health, sorted by how strong the evidence is: what the chemistry of the cup actually measures out to, what the human trials and cohorts support, what the FDA and EFSA have and have not allowed on a label, what milk does, where the ceilings sit, and what the health record looks like in the gardens themselves.
On this page
This office certifies strength. Strength can be weighed. Health cannot, so the two are kept in separate ledgers, and this is the second one. The health record of Assam tea has two halves that are rarely set down together: what a strong, fully oxidised, milk-taking black tea does inside the person drinking it, and what the health record looks like in the gardens that grow it. This office certifies both, at the strength the evidence actually supports and no further.
Each section is certified separately and reads on its own, so stop at the one that answers your question. This page documents the science and prescribes nothing. Tea is a drink, not a treatment, and nothing here is medical advice. Where the evidence is thin the record says so, because a certificate is worth nothing if the office will only certify the pleasant findings.
The chemistry of the cup
Black tea is a manufactured product, and the manufacture is the point. Fresh leaf is loaded with catechins, the small flavan-3-ol molecules most of the world's tea health research was built on, and rolling breaks the leaf's cells and puts its own polyphenol oxidase to work on them. A review of the enzymology in Molecules puts the scale plainly: about 75 percent of the catechins in the leaf1 are oxidised and polymerised into secondary polyphenols, chiefly theaflavins and thearubigins, with theasinensins, theacitrins and oolongtheanins alongside.
Assam pushes that further than most origins, because most Assam is CTC. A 2026 survey in Foods of 32 finished Assam black teas from Upper Assam and the North Bank, run under ISO protocols, states the consequence without softening it: during CTC processing catechin levels fall by about 96 percent2, and in the CTC samples the measured content ran from below detectable limit to low trace. Orthodox is different: the same survey still found EGCG at 0.86 to 12.34 mg/g and ECG at 2.10 to 13.35 mg/g. Every sample in the set met the ISO and FSSAI minimums.
| Fraction | Range across the 32 teas | Average |
|---|---|---|
| Total polyphenols | 83.54 to 184.52 mg/g | 134.07 mg/g |
| Thearubigins (North Bank) | 59.62 to 137.84 mg/g | 110.58 mg/g |
| Theaflavins | 4.88 to 15.54 mg/g | 8.61 mg/g |
| Caffeine | 15.51 to 39.24 mg/g | 30.09 mg/g |
| Theanine | 2.47 to 8.16 mg/g | 5.53 mg/g |
| Monomeric catechins, orthodox | EGCG 0.86 to 12.34, ECG 2.10 to 13.35 mg/g | measurable |
| Monomeric catechins, CTC | below detectable limit to low trace | effectively absent |
The polyphenols are not lost, then. They are converted, and the total stays high. What changes is which molecules you hold, and that is the most important line here: the compound most of the tea health literature is about is the one a cup of CTC Assam has least of. Take that as a mismatch between the evidence base and the cup rather than a verdict against the tea.
The converted fraction is also the less studied one. Thearubigins are the largest group in black tea and the worst characterised, with published estimates spanning roughly 20 to 60 percent of extracted solids depending on the method, and the same review concedes outright that their chemistry is still unclear.
What the human evidence supports
Three bodies of evidence carry real weight. None is about Assam; all are about black tea or tea in general.
The first is a formal guideline. In 2022 a panel working under the Academy of Nutrition and Dietetics and the GRADE framework published the first dietary bioactive guideline for flavan-3-ols, from a review of 157 randomised controlled trials and 15 cohort studies. It suggests that consuming 400 to 600 mg per day of flavan-3-ols can reduce risk associated with cardiovascular disease and diabetes3, from foods low in added sugars, tea among them. The qualifiers are load-bearing. "We suggest" is GRADE's language for a conditional recommendation. Only 48 of the 157 trials were of good methodological quality. Every vascular outcome was assigned low quality evidence except systolic blood pressure, which got moderate. Its own table of food sources ranks brewed black tea second, behind green tea, at 277.32 mg against 318.74 mg. Read that as the guideline's tabulated value rather than the content of your mug: the footnote ties the amount to tea leaves by dry weight, which leaves the serving basis ambiguous.
The second is blood pressure, where three meta-analyses land in the same narrow place. A 2014 pooled analysis of 11 studies and 378 subjects drinking four to five cups daily found systolic pressure lower by 1.8 mmHg and diastolic by 1.3 mmHg4, and discloses that Unilever R&D Vlaardingen funded the review and employs four of its authors. Two independent analyses sit at the low end of the same range: a 2014 British Journal of Nutrition black tea subgroup at 1.4 mmHg systolic and 1.1 diastolic14, and a 2021 Food and Function analysis at 1.04 and 0.5915. Acute intake did nothing. Regular drinking shifts systolic pressure by roughly 1 to 2 mmHg, the largest estimate is the industry-funded one, and nobody has ever felt 1.5 mmHg.
The third is mortality, the closest thing to a black tea study at scale. The UK Biobank cohort followed 498,043 adults aged 40 to 695 for a median 11.2 years, recording 29,783 deaths, and 89 percent of its tea drinkers drank black tea. Against non-drinkers the all-cause hazard ratio, the death rate in one group as a fraction of another's over the follow-up, was 0.95 at one cup or fewer and 0.87 at two to three cups, then 0.88 from four through seven, 0.91 at eight to nine and 0.89 at ten or more. The benefit arrives at two cups a day and then flattens, and ten cups is no better than two. A meta-analysis of 38 prospective cohort data sets covering 1,956,549 participants6, the UK Biobank among them, found the same shape: greatest reduction at 2.0 cups a day and none above it. It carries a caution this office will not bury: it found no significant association between black tea specifically and mortality risk, and called for more large cohorts. The Biobank authors state their own limits: portion size and tea strength were never assessed, and intake was recorded once, at baseline.
What regulators have signed, and what they have not
Certification is this office's trade, so it watches what other bodies have signed. On black tea, close to nothing.
| Body | Subject | Position |
|---|---|---|
| FDA | Black tea, any health claim | No entry on either list. None permitted, none even denied. |
| FDA | Green tea and breast and prostate cancer | Qualified health claim under enforcement discretion, 24 February 2011, updated 17 April 2012. |
| FDA | Green tea and nine named cancers plus total cancers | Denied, 30 June 2005. |
| FDA | Green tea and cardiovascular disease | Denied, 9 May 2006. |
| EFSA NDA Panel | Black tea and improvement of attention | Favourable scientific opinion, 2018. Effect attributed to caffeine. |
No qualified health claim of any kind exists for black tea in the United States. The only tea claims the FDA has allowed to stand7 concern green tea and the risk of breast and prostate cancer, and green tea and cardiovascular disease was refused outright in 20068.
Europe has a favourable opinion, and it repays reading exactly. In 2018 the EFSA NDA Panel, on an application from Unilever, concluded that a cause and effect relationship has been established between the consumption of black tea and improvement of attention9, with the wording "owing to its caffeine content, black tea improves attention," conditional on two to three servings providing at least 75 mg of caffeine in total within 90 minutes. The applicant had argued for a synergy between caffeine and L-theanine. The Panel rejected that framing: the effect can be explained by the caffeine. So the favourable opinion black tea holds in Europe is, on the Panel's own reasoning, an opinion about caffeine. Note the standing precisely too: EFSA issued a scientific opinion, which is not the same act as the European Commission entering a claim in the EU register.
What milk does, and what it does not
Assam is the tea built for milk, so the question is not optional here. Why the two fit, casein binding the tannin that would otherwise pucker, is set out at milk and Assam, which holds the absorption half of the health answer below. The contest resolves along a line between two different things being measured: whether the polyphenols get into you, and whether they do anything once there.
Absorption studies mostly find nothing. Three small crossovers, all with Unilever involvement, found that adding milk changed neither blood catechin levels16 in 12 volunteers in 1998, nor plasma antioxidant activity17 in 21 in 2000, nor flavonol bioavailability18 in 18 in 2001. An independent Indian study in 2005 found the area under the curve for plasma catechins lower with milk, and the antioxidant benefit intact19.
Function studies find something. A 2007 trial in the European Heart Journal put 16 healthy women through flow-mediated dilation, an ultrasound measure of how well an artery widens, taken two hours after a cup: black tea improved it against water, and milk completely blunted the effect20, which the authors attributed to caseins forming complexes with tea catechins. A 2018 randomised crossover in 17 volunteers, four weeks per treatment, found the same direction: black tea raised that measure by 1.00 percent against hot water, milk tea lowered it against both21, and milk tea also raised systolic pressure by 1.1 mmHg and diastolic by 2.0 mmHg where plain black tea moved neither.
Set the two against each other and the difference is the endpoint. A widening artery two hours after a cup is a surrogate marker. Deaths over eleven years are not, and the hard outcomes come from a milk-drinking population. In the UK Biobank cohort the inverse mortality association held among those adding milk, and ran as a clean dose-response among them where the non-milk group showed no association above four to five cups. A 2023 analysis of 498,621 Biobank participants and 21,202 acute kidney injury events22 found risk turning back up at high intake for tea taken without milk, and no such upturn with it: adding milk removed the high-intake risk rather than adding one.
Milk binds tea polyphenols, and it blunts a short-term vascular marker in trials of about sixteen young healthy people, with no meta-analysis behind them. There is no evidence it erases the population-level benefit, and the largest cohort evidence was collected where the milk goes in. Anyone telling you milk cancels out the benefits of tea is over-reading two small trials. The funding cuts both ways: the absorption studies finding no effect lean industry, the function studies finding a blunted marker are academic. Weigh both, discount neither.
The ceilings on a day's drinking
Strength has limits, and this office would rather print them than pretend otherwise.
Caffeine first. EFSA holds that intakes up to 400 mg a day, spread through the day, do not raise safety concerns10 for healthy adults, with single doses up to 200 mg likewise and 200 mg a day the figure in pregnancy. EFSA's own reference figure is 50 mg of caffeine in a 220 ml cup of black tea, which puts the general ceiling at about eight cups a day by its own arithmetic. The FDA cites the same 400 mg for most adults11 and tabulates black tea at 71 mg per 12 fluid ounces, roughly 44 mg per 220 ml. Both are reference values, and neither is a measurement of Assam. What Assam actually carries, by grade and by processing, is measured at Assam tea and caffeine.
Temperature next, and it is the best-graded hazard on this page. The IARC Monographs classed drinking very hot beverages above 65 degrees C (about 150 degrees F) as probably carcinogenic to humans, Group 2A12, for squamous cell carcinoma of the oesophagus, on limited evidence in humans and limited evidence in animals. Read that precisely: the finding is about temperature and not about tea, and it applies as readily to hot water. In a culture that drinks its tea very hot and fast it is the item here most worth acting on, and the action is to let the cup stand a minute.
Oxalate last, and it is the weakest tier of evidence on this page by a distance. A narrative review of oxalate nephropathy in Clinical Kidney Journal tabulates black iced tea among the dietary causes13, on a single case report of sixteen 8 oz glasses daily with a daily oxalate intake above 1,500 mg, and mentions another case of ten cups a day. Case reports sit at the bottom of the evidence hierarchy and describe one person each, and the review cautions that oxalate content varies broadly by measurement method, preparation and cultivar. No trial exists: extreme daily intakes have been implicated in individual cases, and ordinary drinking has not.
One ceiling is not about the leaf at all. Fluoride in Assam is overwhelmingly a groundwater question, weighed at fluoride in the water, not the tea.
Whether anyone checks what is in the packet
The letters on a packet certify leaf size and make, which is what the grade alphabet is for. They certify nothing about residue. That is a separate question, and the answer is not comfortable.
Nationally, the Tea Board's own testing found 835 of 1,764 packet tea samples failing on safety in its 2025-26 round, a record this office has set out in full elsewhere. What the number cannot tell you is why a failure rate like that persists. For that you have to read Assamese.
Asomiya Pratidin, reporting on the state's small tea growers in 2024, put the testing capacity on the record. There is no adequate facility in Assam for the test24. It is done only at the Tocklai Tea Research Institute, which can process just 10 to 15 samples a day, so samples travel from Assam to Kolkata, results take 10 to 15 days, and a small grower pays up to 4,000 rupees (about US$48) for each one. Those figures are that paper's reporting and were not independently confirmable. Fifteen samples a day cannot cover an industry of Assam's size.
The hole was named from inside the industry three years earlier. In a signed 2021 column in the same paper, Pranab Kumar Sarma, a former superintending manager at Tezpur Tea Company Limited, wrote that at the moment green leaf reaches the factory, no machine has yet appeared that can check how much pesticide residue is in that tea25. That is one former manager's account rather than reporting, and this office marks it as such. Neither statement appears in the English-language coverage this office could find.
The health record in the gardens
A cup has two ends. This office certifies both, and the second is documented better in Assamese, Bengali and Hindi than in English.
Start with the statutory fact, which explains the structure of everything downstream. In a written answer in the Lok Sabha in December 2023, the Ministry of Labour and Employment confirmed that tea industry workers fall under the social security laws on gratuity, pension, bonus, maternity benefit and wages, but that plantation workers are not covered under the Employees' State Insurance Act, 194826. India's main contributory health insurance scheme for industrial workers does not reach the gardens, which is why the garden runs its own hospital, an obligation set out in full at the garden hospital law.
What that hospital treats is on the record from the state's own health minister. Announcing the conversion of 354 tea garden hospitals into Ayushman Arogya Mandirs, each with a government community health officer and a twelve-service package, health minister Ashok Singhal enumerated the burden in Assamese: anaemia and malnutrition, high rates of maternal and newborn mortality, non-communicable disease such as high blood pressure and diabetes, and communicable disease including TB, leprosy and diarrhoea, all seen at higher rates in the state's tea garden areas27. The English wire copy of the same announcement does not carry that list. The women's half of the record, reviewed sociologically, is weighed at the tea garden women's health gap.
One finding is sharper than the general burden. A study of four named gardens, Greenwood, Maijan, Bokel and Chabua, combined population 20,903, measured chronic pulmonary aspergillosis at 60 per 100,000 against a reported global 42 per 100,00023. The team attributed it to tuberculosis, which scars the lungs the fungus then colonises, and to the density of garden housing that spreads TB in the first place. The lead researcher, Dr Rima Nath of Assam Medical College in Dibrugarh, rejected a pesticide link28 and cautioned that the tea-garden concentration partly reflects where the study looked, since lung disease is not confined to the gardens.
Money has moved against this record. Uttarbanga Sambad reports that in the union budget for the 2021 to 2022 financial year the finance minister announced 10 billion rupees (about US$120 million) for the development of women and children in the tea gardens of Assam and North Bengal29, of which 6.84 billion rupees (about US$82 million) went to Assam, funding mobile medical units and door-to-door checks in gardens including Jutlibari and Moran. Whether that changes the record above is not yet itself a matter of record.
How to read a health claim about Assam
Four tests will dispose of most of what you will be told. Ask which molecule the study measured, because if it measured catechins it measured something a cup of CTC Assam has almost none of. Ask for the effect size in plain units: 1.5 mmHg is a real measurement and an imperceptible one. Ask who paid, and apply that scepticism symmetrically instead of only to the result you dislike. Ask whether any regulator has signed it, because the FDA never has and EFSA has signed one opinion that turns out to be about caffeine.
Then apply the gap, the most useful thing on this page and the least flattering to it. A systematic search of the Europe PMC literature turns up no clinical trial and no cohort study of Assam tea drinkers with a health outcome. "Assam tea" in the international literature usually denotes Camellia sinensis var. assamica as plant material, often in Thai or Chinese work, not Assam-origin tea in the people drinking it. Every number on the drinking side of this page is borrowed, either from black tea in general or from the leaf rather than the drinker.
The nearest exception used tea as a delivery vehicle rather than as the subject. A trial at Assam Medical College and Hospital gave 60 women a daily cup brewed from 2 g of CTC tea for 90 days30, half plain and half fortified with folate and B12, in a group where 89 percent had low folate status and 72 percent low B12. The plain CTC arm barely moved either marker: serum folate up 1.3 ng/mL, B12 up 1 pg/mL, both clinically insignificant. It did carry one finding for the drinker. Despite borderline low normal iron status in most of the women, the tea, consumed about two hours away from meals, showed no adverse effect on transferrin saturation or on haemoglobin, the measures of how much iron the blood is carrying, and that timing qualifier is load-bearing. The full interaction between tea tannins and iron, and the anaemia record in the gardens, is set out at tannins, iron and anaemia.
The record stands as follows. Two to three cups a day is where the cohort evidence is strongest and where the curve stops rising. Let the cup cool below 65 degrees C. Keep the day's caffeine under 400 mg, about eight cups on EFSA's reference figure and fewer if you also drink coffee. Put milk in it if you want milk in it. Past that, drink Assam because it is brisk, malty and strong enough to start the day, which is the only property of it this office can actually weigh.